Results 101 to 110 of about 8,472 (213)

Transjugular Intrahepatic Portosystemic Shunt and Nursing

open access: yesHuli yanjiu, 1995
From l993 Transjugular intrahepatic portosystemic shunt was performed on 10 patients with portal hypertension due to cirrhosis in our hospital.The results were good.In this paper the therapy,operative procedure and mechanism were discussed.The authors ...
邓惠欢
doaj  

Outcome of Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis and Refractory Hepatic Hydrothorax: A Systematic Review and Meta-analysis

open access: yesIndian Journal of Radiology and Imaging
Background Around 5% of patients with cirrhosis of the liver develop hepatic hydrothorax (HH). For patients with refractory HH (RHH), transjugular intrahepatic portosystemic shunt (TIPS) has been investigated in small studies.
Suprabhat Giri   +7 more
doaj   +1 more source

Transjugular intrahepatic portosystemic shunt trends in China: A brief review

open access: yes, 2018
Transjugular intrahepatic portosystemic shunt (TIPS) is now considered as a major treatment option for cirrhotic patients with portal hypertension. Globally, it is getting markedly increase attention, and a similar phenomenon is occurring in China.
ZhuGe YuZheng, Xiao JiangQiang
core   +1 more source

Minilaparotomy-Assisted Transmesenteric-Transjugular Intrahepatic Portosystemic Shunt: Comparison with Conventional Transjugular Approach

open access: yes, 2016
This study was performed to compare the intrahepatic shunt function outcome and procedural complications of minilaparotomy-assisted transmesenteric (MAT)-transjugular intrahepatic portosystemic shunt (TIPS) placement with the conventional transjugular ...
Jalaeian, Hamed   +7 more
core   +1 more source

Hepatic sinusoidal obstruction syndrome caused by Gynura japonica once misdiagnosed as pancreatitis: a case report and review of literature

open access: yesJournal of Medical Case Reports
Introduction Hepatic sinusoidal obstruction syndrome is a hepatic vascular disease characterized by intrahepatic congestion, liver function damage, and portal hypertension marked by edema, necrosis, and detachment of endothelial cells in the hepatic ...
Ju Wang   +5 more
doaj   +1 more source

Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis

open access: yes, 2018
Transjugular intrahepatic portosystemic shunt (TIPS) is adopted to treat refractory complications of portal hypertension, such as variceal bleeding and ascites.
Alessandro Vit   +19 more
core   +1 more source

Transjugular intrahepatic portosystemic shunt

open access: yes, 2019
Tato bakalářská práce předkládá poznatky o transjugulárním intrahepatickém portosystémovém shuntu (TIPS). Tato minimálně invazivní metoda se využívá při léčbě portální hypertenze, zejména při krvácení do trávicí trubice a při ascitu.
Trollerová, Michaela
core  

Long-term outcome of transjugular intrahepatic portosystemic shunt for portal hypertension in autosomal recessive polycystic kidney disease

open access: yes, 2018
Autosomal recessive polycystic kidney disease (ARPKD) with congenital hepatic fibrosis (CHF) causes portal hypertension and its complications. A transjugular intrahepatic portosystemic shunt (TIPSS) could serve as a symptomatic treatment for portal ...
Sarah Verbeeck   +9 more
core   +1 more source

Transjugular intrahepatic portosystemic stent shunt as a rescue treatment after sclerotherapy failure in variceal bleeding

open access: yes, 1994
Variceal bleeding carries high early mortality, especially after failure of conventional treatments such as endoscopic injection therapy. The present study analyses the efficacy of transjugular intrahepatic portosystemic stent shunt (TIPS) in cirrhotic ...
Bourgeois, Nadine   +7 more
core   +1 more source

Indications and outcomes of transjugular intrahepatic portosystemic shunt insertion in a regional hepatology center

open access: yes, 2019
Background and Aim: Transjugular intrahepatic portosystemic shunt (TIPS) is an established therapeutic option for treating complications of portal hypertension, including refractory ascites and variceal bleeding.
Leschke, P   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy